Anticoagulation Monitoring with Activated Partial ThromboPlastin Time and Anti-Xa Activity in Intensive Care Unit Patients: Interest of Thrombin Generation Assay.

MLA

Billoir, Paul, et al. “Anticoagulation Monitoring with Activated Partial ThromboPlastin Time and Anti-Xa Activity in Intensive Care Unit Patients: Interest of Thrombin Generation Assay.” International Journal of Molecular Sciences, vol. 23, no. 19, Oct. 2022, p. 11219. EBSCOhost, https://doi.org/10.3390/ijms231911219.

APA

Billoir, P., Elie, T., Levy, J. H., Besnier, E., Dureuil, B., Veber, B., Le Cam-Duchez, V., & Clavier, T. (2022). Anticoagulation Monitoring with Activated Partial ThromboPlastin Time and Anti-Xa Activity in Intensive Care Unit Patients: Interest of Thrombin Generation Assay. International Journal of Molecular Sciences, 23(19), 11219. https://doi.org/10.3390/ijms231911219

Chicago

Billoir, Paul, Thomas Elie, Jerrold H. Levy, Emmanuel Besnier, Bertrand Dureuil, Benoit Veber, Véronique Le Cam-Duchez, and Thomas Clavier. 2022. “Anticoagulation Monitoring with Activated Partial ThromboPlastin Time and Anti-Xa Activity in Intensive Care Unit Patients: Interest of Thrombin Generation Assay.” International Journal of Molecular Sciences 23 (19): 11219. doi:10.3390/ijms231911219.